(3R,4S,5S,6R)-2-(4-chloro-3-(4-(((R)-tetrahydrofuran-3-yl)oxy)benzyl)phenyl)-6-(hydroxymethyl)-2-methoxytetrahydro-2H-pyran-3,4,5-triol

It serves as a synthetic intermediate, typically undergoing methoxy-reduction to produce the final, active drug form. The compound (3R,4S,5S,6R)-2-(4-chloro-3-(4-(((R)-tetrahydrofuran-3-yl)oxy)benzyl)phenyl)-6-(hydroxymethyl)-2-methoxytetrahydro-2H-pyran-3,4,5-triol is a methoxy-substituted derivative of the SGLT2 inhibitor Empagliflozin (or its stereoisomer).